Paclitaxel treatment demonstrates lower risk for recurrence

paclitaxol treatment

Another good news on cancer treatment, using paclitaxel.This substance, or now become popular cancer medication, is originated from a tree species called pacific yew. Scientists were trying to develop sysntetis form instead of utlizing natural.

According Healio, treatment with paclitaxel and trastuzumab continued to demonstrate a low risk for recurrence when used as adjuvant therapy for breast cancer, according to a 7-year follow-up analysis from the APT trial presented at the ASCO Annual Meeting.

Healio reports researchers enrolled patients with HER-2–positive breast cancer (IHC 3+ and/or FISH ratio > 2.0) in this single-arm, multicenter, phase 2 study. Patients were required to have a tumor less than three centimeters in size and negative nodes, although one axillary lymph node micro-metastasis was permitted.